{
    "2018-12-29": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Forget GlaxoSmithKline, Eli Lilly Is a Better Big Pharma Stock",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "GlaxoSmithKline",
                        "Better",
                        "Big Pharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan",
                "features": {
                    "keywords": [
                        "Conatus",
                        "CNAT",
                        "NASH",
                        "Emricasan",
                        "Developing"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}